Mediclay Pharmaceuticals Private Limited

Mediclay Pharmaceuticals Private Limited - chemicals in Delhi, India. Directors, charges & compliance details.
CIN U24100DL2022PTC398585 Incorporated 19 May 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals
Revenue · FY 2024
₹67,123
▲ 126% YoY
Net profit · FY 2024
₹9,414
Net margin 14%
EBITDA · FY 2024
₹12,724
EBITDA margin 19%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Mediclay Pharmaceuticals Private Limited

Data last updated:

Mediclay Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 May 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2022PTC398585.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pramendra Kumar and Shashank Shekhar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 2/928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094.

As per the financials filed for FY 2024, the company reported a revenue of ₹67,123, a growth of 126% compared to the previous year. For the same year it recorded a net profit of ₹9,414 (net margin 14%) and EBITDA of ₹12,724 (EBITDA margin 19%).

Company details

CIN U24100DL2022PTC398585
Registration Number 398585
Incorporation Date 19 May 2022
ROC Delhi
Listing Status Unlisted
Company Status Active

Contact details

Mediclay Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.

  • Registered Address
    E – 2/928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094
  • Industry
    Chemicals, Manufacturing, Basic Chemical
Comprehensive company report
Mediclay Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mediclay Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Mediclay Pharmaceuticals Private Limited, buy the company report.

Financials of Mediclay Pharmaceuticals Private Limited

FY 2025 filings available

Mediclay Pharmaceuticals Private Limited reported revenue of ₹67,123 (up 126% YoY) for FY 2024.

Revenue · FY 2024
₹67,123 ▲ 126%
Net profit · FY 2024
₹9,414 margin 14%
EBITDA · FY 2024
₹12,724 margin 19%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 126%
EBITDA CAGR growth
1 year
▲ 576%

Revenue rose 126% in the latest year. EBITDA rose 576% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹12,724
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9,414
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin19%
Net Profit Margin14%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mediclay Pharmaceuticals Private Limited, buy the company report.

Board of directors of Mediclay Pharmaceuticals Private Limited

Mediclay Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pramendra KumarDirector19 May 20224 Years 5 MonthsCurrent
Shashank ShekharAdditional Director12 Jan 20251 Years 10 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mediclay Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Mediclay Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Mediclay Pharmaceuticals Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Chandani Kumari ceased to be Director on 12 Jan 2025.

AGM
Mediclay Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mediclay Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Chandani Kumari ceased to be Director.
Appointed
Shashank Shekhar was appointed as Additional Director.
Appointed
Chandani Kumari was appointed as Director.
Appointed
Pramendra Kumar was appointed as Director.
Incorporation
19 May 2022
Mediclay Pharmaceuticals Private Limited was registered on 19 May 2022 with Roc Delhi & aged 4 years 6 months as per MCA records.

Frequently asked questions

Mediclay Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 May 2022 (4+ years old) and is registered under CIN U24100DL2022PTC398585.

Mediclay Pharmaceuticals has 2 current directors:

The latest financial statements of Mediclay Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Mediclay Pharmaceuticals is U24100DL2022PTC398585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mediclay Pharmaceuticals was incorporated on 19 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

Chandani Kumari ceased to be Director on 12 Jan 2025. Shashank Shekhar was appointed as Additional Director on 12 Jan 2025. Chandani Kumari was appointed as Director on 19 May 2022. Mediclay Pharmaceuticals has 4 board changes on record in total.

The registered office of Mediclay Pharmaceuticals is at E – 2928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094.

Mediclay Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Mediclay Pharmaceuticals can be reached at its registered office: E – 2928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094.

Mediclay Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.